Oz Biosciences USA Inc

Building Scientist LLC is a San Diego-based company specializing in providing innovative solutions for building performance. With a focus on sustainability and energy efficiency, they offer consulting services to optimize the functionality and environmental impact of residential and commercial properties. Utilizing advanced technology and industry expertise, Building Scientist LLC assists clients in achieving their goals of creating healthier and more efficient living and working spaces. Their comprehensive approach to building science ensures that each project is tailored to meet the unique needs and objectives of their customers. Generated from their business information

EHS Analytical Solutions, Inc. is a leading environmental health and safety consulting firm based in San Diego, CA. They specialize in providing professional EHS consulting and safety staffing services to businesses in various sectors, including biotech, construction, pharmaceutical, manufacturing, industrial, and aerospace industries. Their mission is to help clients reduce operational costs, meet compliance objectives, and minimize risk and liability by offering cost-effective solutions and expertise from certified EHS consultants. With a team of industry experts, including certified industrial hygienists, safety professionals, asbestos consultants, and environmental specialists, EHS Analytical Solutions ensures that clients receive efficient, high-quality, and affordable support. They offer a comprehensive range of services, including EHS consulting, construction safety consulting, industrial hygiene services, indoor air quality testing, mold testing, asbestos testing, water damage assessments, and fire smoke assessments. Whether it's meeting complex regulatory requirements or improving safety performance, EHS Analytical Solutions is dedicated to providing tailored solutions to meet the unique needs of each client.Generated from the website

MD2 Biosciences Inc. is a San Diego-based biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutics primarily focused on oncology. With a commitment to addressing significant unmet medical needs, the company aims to develop best-in-class or first-in-class programs to enhance and extend the lives of patients suffering from various cancers. Utilizing innovative artificial intelligence techniques in their drug discovery and optimization processes, MD2 Biosciences has created a unique platform that identifies small-molecule hits for flat proteins. This cutting-edge approach, combined with their expertise in medicinal chemistry, allows the company to generate novel lead compounds tailored for effective administration routes, including oral and intravenous options, while also facilitating central nervous system delivery. Generated from the website